Rank Based on U.S. News Score. |
23 |
U.S. News Score Summarizes quality of care. The top-ranked hospital received a score of 100. |
35.0 |
Reputation Percentage of specialists responding to U.S. News surveys who recommended hospital for difficult cases. |
2.2% |
Infection prevention index Involvement and performance in infection-reducing activities such as hand hygiene, flu vaccination, and case reporting. Higher is better. |
5 |
Patient volume All patients in most recent 12 months who had specified disorders or received specified procedures. |
Medium |
Nurse staffing Relative balance of nurses and patients. Higher is better. |
2.0 |
Nurse Magnet hospital Meets certain standards set by the American Nurses Credentialing Center. |
No |
Advanced clinical services (of 11) Examples:primary hematologist-oncologist for each patient, brain tumor program, bone or soft tissue sarcoma program, pharmacist rounds daily with inpatient care team, long-term survivors program, satellite offices or outreach clinics, coordinated community-based follow-up care, participation in tumor registry. |
10 |
Key technologies (of 10) PET or PET/CT scan, intraoperative MRI, 3-Tesla MRI, image-guided radiation therapy, intensity-modulated radiation therapy, bone scan, shaped-beam stereotactic radiation therapy, multislice CT, I-131 MIBG imaging agent, magnetic resonance spectroscopy. |
10 |
Patient and family services (of 8) Certified child life specialists, family support specialists, pediatric psychologists, interpreter services, family resource center, sleep rooms for parents/siblings, school intervention program, Ronald McDonald House or other residential facility for parents. |
8 |
Palliative care (of 2) Has staff trained to help children cope with terminal or life-limiting conditions and available to cancer patients. |
2 |
FACT accreditation Meets Foundation for the Accreditation of Cellular Therapy standards for bone marrow and tissue transplantation. |
Yes |
Participation in cancer research (of 5) Takes part in cancer research network; initiates phase I and II clinical trials in leukemia, brain tumors, sarcomas, or neuroblastomas. |
5 |
Cancer
Diabetes & Endocrine Disorders